Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-positive Breast Cancer|Invasive Ductal Breast Carcinoma|Progesterone Receptor-positive Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer
Interventions: DRUG: zoledronic acid|OTHER: laboratory biomarker analysis|PROCEDURE: therapeutic conventional surgery
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)